Showing results (191-200 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|June 28, 2014
Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patientsCarla Moran, Maura Agostini, W Edward Visser, et al.
The Lancet. Diabetes & Endocrinology|June 6, 2014
Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trialTali Cukierman-Yaffe, Jackie Bosch, Rafael Diaz, et al.
The Lancet. Diabetes & Endocrinology|July 25, 2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysisMilad Nazarzadeh, Zeinab Bidel, Dexter Canoy, et al.
The Lancet. Diabetes & Endocrinology|June 26, 2018
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, et al.
The Lancet. Diabetes & Endocrinology|May 13, 2018
Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies
The Lancet. Diabetes & Endocrinology|August 18, 2018
Glycaemic variability in diabetes: clinical and therapeutic implicationsAntonio Ceriello, Louis Monnier, David Owens
The Lancet. Diabetes & Endocrinology|June 14, 2019
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trialThomas R Pieber, Bruce Bode, Ann Mertens, et al.
The Lancet. Diabetes & Endocrinology|June 21, 2014
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trialMartin Ridderstråle, Knut Robert Andersen, Cordula Zeller, et al.
The Lancet. Diabetes & Endocrinology|September 5, 2021
Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based studyShivani Misra, Emma Barron, Eszter Vamos, et al.
The Lancet. Diabetes & Endocrinology|September 5, 2021
Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoriaChristel Jm de Blok, Chantal M Wiepjes, Daan M van Velzen, et al.
Pageof 93